Company news_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

04-24

InnoModels Biotechnology: Introduction to the characteristics of dual humanized models

In the field of biomedical research, animal models have always been an indispensable and important tool. However, traditional animal models often fail to fully simulate human physiological and pathological processes and have certain limitations. In order to solve this problem, InnoModels Biotechnology has launched the Dual Humanized Model. The model is based on human cells and tissues, constructed through advanced bioengineering technology, with a very high degree of simulation and practicability, opening up a new path for biomedical research.

04-23

InnoModels Biotechnology: Features and Innovations of GVHD Experimental Platforms

GVHD (graft-versus-host disease) has always been a complex and important topic in the field of biomedical research. With its unique features and cutting-edge technology, the GVHD experimental platform of InnoModels Biotechnology is gradually becoming a research plateau in this field. In this article, we would like to introduce several major features of the GVHD experimental platform, in order to provide new ideas and methods for the majority of researchers.

04-22

InnoModels Biotechnology: Advantages of Humanized Models of the Immune System

With the rapid development of the biomedical field, understanding the function of the immune system and disease mechanisms has become an important prerequisite for disease diagnosis and treatment. As an advanced biomedical research tool, the humanized model of the immune system is helping us to gain a deeper understanding of the complexity and diversity of the human immune system, and advancing the progress of medical research.

04-19

InnoModels Biotechnology ELISA Platform: A Powerful Tool to Precisely Analyze Biomolecular Interactions

Enzyme-linked immunosorbent assay (ELISA) has become a crucial technique in biological science and medical research, and is widely used for the qualitative and quantitative analysis of biomolecules such as proteins, antibodies and antigens. With its unique features, InnoModels Bio's ELISA platform provides researchers with accurate, reliable and efficient testing solutions.

< 1...26 27 28...61 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License